This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1979 Nov 29;301(22):1241-2.

doi: 10.1056/nejm197911293012218.

Tamoxifen in malignant melanoma

R A Nesbit, R L Woods, M H Tattersall, R M Fox, J F Forbes, I R MacKay, M Goodyear

PMID: 503125
DOI: 10.1056/nejm197911293012218

Case Reports

Tamoxifen in malignant melanoma

R A Nesbit et al. N Engl J Med. 1979.

. 1979 Nov 29;301(22):1241-2.

doi: 10.1056/nejm197911293012218.

Authors

R A Nesbit, R L Woods, M H Tattersall, R M Fox, J F Forbes, I R MacKay, M Goodyear

PMID: 503125
DOI: 10.1056/nejm197911293012218

No abstract available

PubMed Disclaimer

Similar articles

Long-term remissions in metastatic malignant melanoma following chemotherapy and tamoxifen maintenance.
Metzner B, Casper J, Hartung G, Rosien B, Hölzle E, Pelzer P, Köhne CH. Metzner B, et al. Onkologie. 2011;34(4):208-9. doi: 10.1159/000327003. Epub 2011 Mar 18. Onkologie. 2011. PMID: 21447982 No abstract available.
Tamoxifen in metastatic malignant melanoma.
Meyskens FL Jr, Voakes JB. Meyskens FL Jr, et al. Cancer Treat Rep. 1980 Jan;64(1):171-3. Cancer Treat Rep. 1980. PMID: 7379053
Long-term complete remission of malignant melanoma with tamoxifen.
Mirimanoff RO, Wagenknecht L, Hunziker N. Mirimanoff RO, et al. Lancet. 1981 Jun 20;1(8234):1368-9. doi: 10.1016/s0140-6736(81)92545-9. Lancet. 1981. PMID: 6113337 No abstract available.
[Chemotherapy of malignant melanoma].
Avril MF. Avril MF. Ann Dermatol Venereol. 1988;115(9):959-68. Ann Dermatol Venereol. 1988. PMID: 2464963 Review. French. No abstract available.
Tamoxifen vs. non-tamoxifen treatment for advanced melanoma: a meta-analysis.
Beguerie JR, Xingzhong J, Valdez RP. Beguerie JR, et al. Int J Dermatol. 2010 Oct;49(10):1194-202. doi: 10.1111/j.1365-4632.2010.04529.x. Int J Dermatol. 2010. PMID: 20883410 Review.

See all similar articles

Cited by

Topical toremifene: a new approach for cutaneous melanoma?
Maenpaa J, Dooley T, Wurz G, VandeBerg J, Robinson E, Emshoff V, Sipila P, Wiebe V, Day C, DeGregorio M. Maenpaa J, et al. Cancer Chemother Pharmacol. 1993;32(5):392-5. doi: 10.1007/BF00735925. Cancer Chemother Pharmacol. 1993. PMID: 8339391
Amelanotic malignant melanoma of the esophagus: report of a patient with recurrence successfully treated with chemoendocrine therapy.
Suzuki Y, Aoyama N, Minamide J, Takata K, Ogata T. Suzuki Y, et al. Int J Clin Oncol. 2005 Jun;10(3):204-7. doi: 10.1007/s10147-004-0473-6. Int J Clin Oncol. 2005. PMID: 15990972
Steroid hormone receptors in human melanoma.
Grill HJ, Benes P, Manz B, Schramm P, Morsches B, Korting GW, Pollow K. Grill HJ, et al. Arch Dermatol Res. 1982;272(1-2):97-101. doi: 10.1007/BF00510399. Arch Dermatol Res. 1982. PMID: 7165327
Oral contraceptive use and risk of melanoma in premenopausal women.
Feskanich D, Hunter DJ, Willett WC, Spiegelman D, Stampfer MJ, Speizer FE, Colditz GA. Feskanich D, et al. Br J Cancer. 1999 Nov;81(5):918-23. doi: 10.1038/sj.bjc.6690787. Br J Cancer. 1999. PMID: 10555769 Free PMC article.
Alopecia with endocrine therapies in patients with cancer.
Saggar V, Wu S, Dickler MN, Lacouture ME. Saggar V, et al. Oncologist. 2013;18(10):1126-34. doi: 10.1634/theoncologist.2013-0193. Epub 2013 Sep 13. Oncologist. 2013. PMID: 24037977 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.